Table 3.
Unadjusted and adjusted analyses of neutrophil counts and NLR with high SHR group according to TOAST classification of ischemic stroke etiology.
| Variables | Unadjusted model | Multivariable- Model | ||
| OR (95% CI) | p value | OR (95% CI) | p value | |
| Neutrophil, ×109/L | ||||
|---|---|---|---|---|
| LAA | 1.296(1.141-1.472) | P<0.001 | 2.047(1.355-3.093) | 0.001 |
| CE | 1.466(1.093-1.965) | 0.011 | 2.413(1.081-5.383) | 0.031 |
| SVO | 0.974(0.744-1.274) | 0.847 | 0.974(0.744-1.274) | 0.847 |
| NLR | ||||
| LAA | 1.298(1.143-1.473) | P<0.001 | 1.315(1.129-1.530) | P<0.001 |
| CE | 1.332(1.050-1.690) | 0.018 | 1.436(0.938-2.197) | 0.095 |
| SVO | 1.005(0.805-1.255) | 0.966 | 1.035(0.818-1.308) | 0.777 |
LAA Multivariable- Model: adjusted for:sex, age, hyperlipidemia, DM, SBP, WBC, TG, TC, HDL, LDL.CE Multivariable- Model: adjusted for sex, age, DM, SBP, WBC, TC.SVO Multivariable- Model: adjusted for:sex, age, DM. TOAST: Trial of Org 10172 in Acute Stroke Treatment; LAA, large-artery atherosclerosis; CE, cardioembolism; SVO, small-vessel occlusion; OR, odds ratio; NLR, neutrophil-to-lymphocyte ratio; DM, diabetes mellitus; SBP, systolic blood pressure; WBC, white blood cells; TG, triglycerides; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein.